myTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials

myTomorrows Team 27 Aug 2024

4 mins read

share this post

myTomorrows and Pancreatic Cancer Europe Partnership

Partnership with the European patient advocacy group furthers myTomorrows’ mission to expand access to all possible treatment options for patients suffering from a variety of life-threatening illnesses.

(Amsterdam – 27 AUGUST, 2024) – myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with Pancreatic Cancer Europe, a multi-stakeholder platform that brings together experts from all over Europe with a common interest and willingness to improve care for patients with pancreatic cancer. Through the new partnership, Pancreatic Cancer Europe (PCE) will utilize myTomorrows’ search engine of ongoing clinical trials to equip patients, caregivers and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them.  

Pancreatic cancer is the fourth leading cause of cancer deaths, with a life expectancy of only 6-12 months at time of diagnosis and a 5-year survival rate of only 10%. The many challenges associated with pancreatic cancer include a lack of awareness about the disease among the public, difficulty in diagnosis, which is late, treatment resistance to chemo and radiation therapy, poor survival rates, and limited treatments. Therefore, it is crucial for patients to be as accurately and thoroughly informed as possible about their treatment options – especially clinical trials, which are often difficult to find, understand, and navigate. 

For pancreatic cancer patients, their loved ones, and the Healthcare Professionals (HPCs) who treat them, the partnership will ease the process of identifying and understanding the existing clinical trial options. In doing so, it will enable them to make the best possible decisions about their treatment, with myTomorrows’ expert patient navigators demystifying the complexities of clinical trials and supporting patients and their families throughout the process. A new clinical trial search tool, which will be featured on the Pancreatic Cancer Europe website, will make it even easier and quicker to search for relevant treatment options across myTomorrows’ vast database of ongoing clinical trials worldwide.  

“We are very excited to be partnering with Pancreatic Cancer Europe, an organisation that works tirelessly to raise awareness of pancreatic cancer, promote advancements in treatments, and empower European member organisations to better address the relevant issues regarding the disease,” said Dr. Michel van Harten, CEO of myTomorrows. “Collaborating with leading patient advocacy groups like PCE helps us extend our reach to more patients in need and empower them to navigate their treatment journeys with more confidence and knowledge, while enabling pharmaceutical companies to expand access throughout the drug development cycle.” 

“This new partnership is an important step in the persistent fight against pancreatic cancer,” said Prof. Alfredo Carrato, Chair of Pancreatic Cancer Europe. “The innovative myTomorrows platform will support patients suffering from pancreatic cancer, their caregivers and their treating physicians by significantly easing the process of accessing and navigating clinical trials, another opportunity for them, enabling a more informed and proactive approach to treatment of this devastating disease.” 

To learn more about available clinical trials and the people impacted by pancreatic cancer including patients, their caregivers, and physicians click here. 

  

About myTomorrows: 

myTomorrows is a global healthtech company dedicated to breaking down barriers for patients seeking treatment options. To make this a reality, the company has built powerful technology that enable a comprehensive search of clinical trials databases worldwide, efficiently connecting patients, physicians, trial sites and BioPharma to support straightforward and transparent access to drugs in development. Headquartered in Amsterdam with an office in New York City, myTomorrows has helped more than 5,000 patients and 500 physicians in over 80 countries to date.  

www.mytomorrows.com 

  

myTomorrows Media Contact: 

Ben Crome 

Headline Media 

ben@headline.media 

+1 914 336 4922 

  

About Pancreatic Cancer Europe: 

Pancreatic Cancer Europe is a European multi-stakeholder platform which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups and journalists with a common interest and willingness to improve care for patients with pancreatic cancer. 

https://pancreaticcancereurope.eu/   

 

Pancreatic Cancer Europe Media Contact: 

Priya Raja 

Communication Officer 

info@pancreaticcancereurope.eu 

share this post

Clinical TrialsPancreatic CancerPartnership

myTomorrows Team 27 Aug 2024

Stay Up to Date

Signup to our newsletter for updates

more articles

view all blogs
Physicians
HCPs
Medical Community
Dedicated support

Meet the myTomorrows medical community team!

myTomorrows Team

22 Nov 2024

4 mins read

Vanessa Lemarie

myTomorrows Appoints Vanessa Lemarié as Chief Operating Officer

myTomorrows Team

13 Nov 2024

3 mins read

Clinical Research
Research Studies
Investigational treatments
Brain Tumours

From Symptoms to Treatment: A Guide to Brain Tumours

myTomorrows Team

27 Sep 2024

10 mins read

Clinical Research
Research Studies
Investigational treatments
Becker Muscular Dystrophy

Navigating Becker Muscular Dystrophy: Symptoms, Diagnosis, and Treatment Options

myTomorrows Team

27 Sep 2024

8 mins read

disabled-boy-in-a-wheelchair-enjoying-the-day-outdoors
Duchenne Muscular Dystrophy
Clinical Research
Research Studies
Investigational treatments

Living with Duchenne Muscular Dystrophy: Treatment and Care Essentials 

myTomorrows Team

27 Sep 2024

11 mins read

Investigational treatments
Limb-Girdle Muscular Dystrophy
Research Studies
Clinical Research

From Diagnosis to Treatment: Managing Limb-Girdle Muscular Dystrophy

myTomorrows Team

17 Sep 2024

11 mins read

Mighties
myTomorrowland

The Mighties at myTomorrowland 2024

myTomorrows Team

28 Aug 2024

3 mins read

Group of physicians investigating new therapies for Type 1 Diabetes
Type 1 Diabetes
Clinical Research
Research Studies
Investigational treatments

Emerging Treatments for Type 1 Diabetes

myTomorrows Team

14 Aug 2024

6 mins read

Diversity, Equity and Inclusion, group of friends
Clinical Trials
Drug Development
Clinical Trial Enrollment
Regulatory

Building Effective Diversity, Equity, and Inclusion Strategies in Clinical Trial Recruitment

myTomorrows Team

6 Aug 2024

9 mins read